Detalles de la búsqueda
1.
CD19 CAR-T cell treatment conferred sustained remission in B-ALL patients with minimal residual disease.
Cancer Immunol Immunother
; 70(12): 3501-3511, 2021 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-33899130
2.
Efficacy and safety of humanized anti-CD19-CAR-T therapy following intensive lymphodepleting chemotherapy for refractory/relapsed B acute lymphoblastic leukaemia.
Br J Haematol
; 191(2): 212-222, 2020 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-32232846
3.
Iron overload impairs normal hematopoietic stem and progenitor cells through reactive oxygen species and shortens survival in myelodysplastic syndrome mice.
Haematologica
; 103(10): 1627-1634, 2018 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-29903757
4.
Reactive oxygen species mediated T lymphocyte abnormalities in an iron-overloaded mouse model and iron-overloaded patients with myelodysplastic syndromes.
Ann Hematol
; 96(7): 1085-1095, 2017 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-28421266
5.
[Clinical feature and prognosis analysis of elderly patients with polythemia vera].
Zhonghua Yi Xue Za Zhi
; 95(18): 1374-7, 2015 May 12.
Artículo
en Zh
| MEDLINE | ID: mdl-26178352
6.
Multi-centers experience using therapeutic plasma exchange for corticosteroid/tocilizumab-refractory cytokine release syndrome following CAR-T therapy.
Int Immunopharmacol
; 130: 111761, 2024 Mar 30.
Artículo
en Inglés
| MEDLINE | ID: mdl-38422769
7.
Free iron catalyzes oxidative damage to hematopoietic cells/mesenchymal stem cells in vitro and suppresses hematopoiesis in iron overload patients.
Eur J Haematol
; 91(3): 249-261, 2013 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-23772810
8.
[Reactive oxygen species mediate the injury and deficient hematopoietic supportive capacity of umbilical cord derived mesenchymal stem cells induced by iron overload].
Zhonghua Yi Xue Za Zhi
; 93(12): 930-4, 2013 Mar 26.
Artículo
en Zh
| MEDLINE | ID: mdl-23863680
9.
[Establishment of an mouse model of iron-overload and its impact on bone marrow hematopoiesis].
Zhongguo Yi Xue Ke Xue Yuan Xue Bao
; 35(5): 547-52, 2013 Oct.
Artículo
en Zh
| MEDLINE | ID: mdl-24183045
10.
CAR-T cells dual-target CD123 and NKG2DLs to eradicate AML cells and selectively target immunosuppressive cells.
Oncoimmunology
; 12(1): 2248826, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-37645216
11.
Low-dose administration of prednisone has a good effect on the treatment of prolonged hematologic toxicity post-CD19 CAR-T cell therapy.
Front Immunol
; 14: 1139559, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-36999027
12.
Successful treatment of second-time CAR-T 19 therapy after failure of first-time CAR-T 19 and ibrutinib therapy in relapsed mantle cell lymphoma.
Adv Clin Exp Med
; 31(3): 327-335, 2022 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-35148570
13.
The Value of Metagenomic Next-Generation Sequencing in Hematological Malignancy Patients with Febrile Neutropenia After Empiric Antibiotic Treatment Failure.
Infect Drug Resist
; 15: 3549-3559, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-35837537
14.
Evaluation of the safety and efficacy of humanized anti-CD19 chimeric antigen receptor T-cell therapy in older patients with relapsed/refractory diffuse large B-cell lymphoma based on the comprehensive geriatric assessment system.
Leuk Lymphoma
; 63(2): 353-361, 2022 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-34587859
15.
Metagenomic Next-Generation Sequencing for Diagnostically Challenging Mucormycosis in Patients with Hematological Malignancies.
Infect Drug Resist
; 15: 7509-7517, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-36570711
16.
A Prospective Trial Comparing Haploidentical Donor Transplantation With Cord Blood Versus HLA-Matched Sibling Donor Transplantation for Hematologic Malignancy Patients.
Cell Transplant
; 31: 9636897221076050, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-35168385
17.
[Effect and Involved Mechanism of RSL3-induced Ferroptosis in Acute Leukemia Cells MOLM13 and Drug-resistant Cell Lines].
Zhongguo Shi Yan Xue Ye Xue Za Zhi
; 29(4): 1109-1118, 2021 Aug.
Artículo
en Zh
| MEDLINE | ID: mdl-34362489
18.
Comparison of outcomes of haploidentical donor hematopoietic stem cell transplantation supported by third-party cord blood with HLA-matched unrelated donor transplantation.
Leuk Lymphoma
; 61(4): 840-847, 2020 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-31777304
19.
CAR-T 19 combined with reduced-dose PD-1 blockade therapy for treatment of refractory follicular lymphoma: A case report.
Oncol Lett
; 18(5): 4415-4420, 2019 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-31611950
20.
Plasma Exchange Can Be an Alternative Therapeutic Modality for Severe Cytokine Release Syndrome after Chimeric Antigen Receptor-T Cell Infusion: A Case Report.
Clin Cancer Res
; 25(1): 29-34, 2019 01 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-30322878